Trials / Completed
CompletedNCT00675740
Physical Exercise Versus Rosiglitazone in CAD and Prediabetes
Effects of Physical Exercise Versus Rosiglitazone on Endothelial Function in Coronary Artery Disease Patients With Prediabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- University of Leipzig · Academic / Other
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to prospectively assess the relative benefits of either treatment with rosiglitazone or physical exercise on endothelial function in patients with impaired fasting glucose or impaired glucose tolerance and coronary artery disease (CAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rosiglitazone | tablets 4 mg daily |
| BEHAVIORAL | physical exercise | stationary bike 5-6 times a week |
| OTHER | control | control without intervention |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2008-05-12
- Last updated
- 2010-02-02
Source: ClinicalTrials.gov record NCT00675740. Inclusion in this directory is not an endorsement.